Fund Holdings — RA CAPITAL MANAGEMENT, L.P.

Total Portfolio Value:
$8.67B
Total Bought:
$1.10B
Total Sold:
$465.03M
Net Transaction:
+$630.21M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Ascendis Pharma A/SSH(ASND)10,108,4009,710,428-397,972$1.38B$1.45B16.72%+$71.28M
Vaxcyte, Inc.SH(PCVX)8,203,7548,689,190+485,436$619.47M$992.91M11.45%+$373.45M
Janux Therapeutics, Inc.SH(JANX)9,165,6529,165,6520$383.95M$416.40M4.80%+$32.45M
Legend Biotech CorporationSH(LEGN)7,506,9347,506,9340$332.48M$365.81M4.22%+$33.33M
Rhythm Pharmaceuticals, Inc.SH(RYTM)6,084,4126,084,4120$249.83M$318.76M3.68%+$68.94M
Avidity Biosciences IncSH5,400,4086,300,408+900,000$220.61M$289.38M3.34%+$68.77M
Tyra Biosciences, Inc.SH(TYRA)10,416,60910,416,6090$166.56M$244.89M2.82%+$78.33M
Evolent Health, Inc.SH(EVH)8,514,8628,514,8620$162.80M$240.80M2.78%+$78.00M
Edgewise Therapeutics, Inc.SH(EWTX)8,909,0918,909,0910$160.45M$237.78M2.74%+$77.33M
Biogen Inc.SH(BIIB)982,1391,184,456+202,317$227.68M$229.59M2.65%+$1.92M
Dyne Therapeutics, Inc.SH(DYN)6,049,2046,381,144+331,940$213.48M$229.21M2.64%+$15.73M
RxSight, Inc.SH(RXST)3,694,8253,916,825+222,000$222.32M$193.61M2.23%-$28.71M
Bicara Therapeutics IncSH06,955,993+6,955,993$0$177.17M2.04%+$177.17M
Climb Bio, Inc.SH(CLYM)31,419,26731,419,2670$223.39M$159.92M1.84%-$63.47M
ARS Pharmaceuticals, Inc.SH(SPRY)10,860,97710,860,9770$92.43M$157.48M1.82%+$65.06M
Arcellx IncSH
COMMON STOCK
1,604,0141,851,479+247,465$88.53M$154.62M1.78%+$66.09M
Artiva Biotherapeutics, Inc.SH(ARTV)09,853,302+9,853,302$0$152.23M1.76%+$152.23M
Wave Life Sciences, Inc.SH(WVE)18,202,00918,202,0090$90.83M$149.26M1.72%+$58.43M
Geron CorporationSH(GERN)46,202,42532,285,755-13,916,670$195.90M$146.58M1.69%-$49.32M
Verona Pharma Plc - AdrSH7,632,6465,009,653-2,622,993$110.37M$144.13M1.66%+$33.76M
Newamsterdam Pharma Co NvSH
ORDINARY SHARES
8,064,0008,064,0000$154.91M$133.86M1.54%-$21.05M
Apogee Therapeutics IncSH1,961,8631,961,8630$77.20M$115.24M1.33%+$38.04M
Day One Biopharmaceuticals ISH
COM
7,871,7217,871,7210$108.47M$109.65M1.26%+$1.18M
89bio IncSH14,175,39814,175,3980$113.54M$104.90M1.21%-$8.65M
Recursion Pharmaceuticals, Inc.SH(RXRX)15,384,61515,384,6150$115.38M$101.38M1.17%-$14.00M
LENZ Therapeutics, Inc.SH(LENZ)4,178,8234,178,8230$72.25M$99.21M1.14%+$26.95M
PepGen Inc.SH(PEPG)10,689,54510,689,5450$170.61M$91.40M1.05%-$79.21M
Axsome Therapeutics, Inc.SH(AXSM)1,000,0001,000,0000$80.50M$89.87M1.04%+$9.37M
Structure Therapeutics IncSH1,896,7721,896,7720$74.49M$83.25M0.96%+$8.76M
Tourmaline Bio IncSH2,538,9252,538,9250$32.65M$65.28M0.75%+$32.63M
Dianthus Therapeutics, Inc.SH(DNTH)2,333,0002,333,0000$60.38M$63.88M0.74%+$3.50M
Mineralys Therapeutics, Inc.SH(MLYS)4,850,9844,850,9840$56.76M$58.75M0.68%+$1.99M
Acrivon Therapeutics IncSH8,340,5088,340,5080$48.37M$58.38M0.67%+$10.01M
Astria Therapeutics IncSH5,043,7565,105,213+61,457$45.90M$56.21M0.65%+$10.31M
4d Molecular Therapeutics InSH5,098,2115,098,2110$107.01M$55.11M0.64%-$51.90M
CG Oncology, Inc.SH(CGON)1,397,4331,397,4330$44.12M$52.73M0.61%+$8.61M
Bicycle Therapeutics Plc-AdrSH2,253,0002,253,0000$45.60M$50.99M0.59%+$5.38M
Nkarta, Inc.SH(NKTX)10,805,12910,805,1290$63.86M$48.84M0.56%-$15.02M
BioAge Labs, Inc.SH(BIOA)02,210,589+2,210,589$0$45.98M0.53%+$45.98M
GH Research PLCSH(GHRS)6,601,6896,686,689+85,000$76.98M$44.73M0.52%-$32.24M
Praxis Precision Medicines, Inc.SH(PRAX)1,235,599761,955-473,644$51.10M$43.84M0.51%-$7.26M
IDEAYA Biosciences, Inc.SH(IDYA)01,347,252+1,347,252$0$42.68M0.49%+$42.68M
Larimar Therapeutics, Inc.SH(LRMR)6,045,3516,045,3510$43.83M$39.60M0.46%-$4.23M
MBX Biosciences, Inc.SH(MBX)01,511,334+1,511,334$0$39.26M0.45%+$39.26M
Acumen Pharmaceuticals, Inc.SH(ABOS)14,932,06314,932,0630$36.14M$37.03M0.43%+$895.9K
Fulcrum Therapeutics, Inc.SH(FULC)11,609,70410,229,099-1,380,605$71.98M$36.52M0.42%-$35.46M
Iteos Therapeutics IncSH3,517,2593,184,711-332,548$52.20M$32.52M0.37%-$19.68M
Solid Biosciences IncSH4,330,4464,330,4460$24.55M$30.18M0.35%+$5.63M
C4 Therapeutics, Inc.SH(CCCC)4,878,0004,878,0000$22.54M$27.80M0.32%+$5.27M
Enliven Therapeutics IncSH2,122,4651,061,233-1,061,232$49.60M$27.10M0.31%-$22.50M
Alto Neuroscience, Inc.SH(ANRO)2,085,5542,075,154-10,400$22.29M$23.74M0.27%+$1.45M
Sera Prognostics, Inc.SH(SERA)3,032,8083,032,8080$17.95M$23.66M0.27%+$5.70M
Taysha Gene Therapies, Inc.SH(TSHA)10,872,50310,872,5030$24.35M$21.85M0.25%-$2.50M
Immatics N.V.SH(IMTX)1,750,0001,750,0000$20.34M$19.97M0.23%-$367.5K
Aerovate Therapeutics IncSH9,192,0929,192,0920$15.26M$19.21M0.22%+$3.95M
Nuvalent Inc-ASH119,789176,281+56,492$9.09M$18.03M0.21%+$8.95M
Third Harmonic Bio IncSH2,033,0561,280,826-752,230$26.43M$17.36M0.20%-$9.07M
Vor Biopharma Inc.SH(VOR)22,748,88022,748,8800$22.75M$15.92M0.18%-$6.82M
Insmed IncorporatedSH(INSM)200,000200,0000$13.40M$14.60M0.17%+$1.20M
Pliant Therapeutics, Inc.SH(PLRX)1,281,0001,281,0000$13.77M$14.36M0.17%+$589.3K
Tenaya Therapeutics, Inc.SH(TNYA)7,622,3476,982,587-639,760$23.63M$13.48M0.16%-$10.15M
Zura Bio LimitedSH(ZURA)3,217,5033,217,5030$11.26M$13.06M0.15%+$1.80M
Werewolf Therapeutics, Inc.SH(HOWL)6,144,8816,144,8810$14.99M$13.03M0.15%-$1.97M
CervoMed Inc.SH(CRVO)817,120817,1200$13.99M$11.93M0.14%-$2.06M
Xencor, Inc.SH(XNCR)0575,000+575,000$0$11.56M0.13%+$11.56M
Adicet Bio IncSH7,541,0007,541,0000$9.12M$10.86M0.13%+$1.73M
Arvinas, Inc.SH(ARVN)421,348421,3480$11.22M$10.38M0.12%-$838.5K
Avalo Therapeutics, Inc.SH(AVTX)0967,000+967,000$0$9.19M0.11%+$9.19M
Chimerix IncSH8,800,0008,800,0000$7.71M$8.18M0.09%+$475.2K
Boundless Bio, Inc.SH(BOLD)2,180,6312,180,6310$8.44M$7.57M0.09%-$872.3K
Cidara Thereapeutics IncSH0703,080+703,080$0$7.56M0.09%+$7.56M
Perceptive Capital SolutionsSH
CL A ORD SHS
750,000750,0000$7.54M$7.51M0.09%-$30.0K
Lexeo Therapeutics, Inc.SH(LXEO)672,712546,554-126,158$10.79M$4.94M0.06%-$5.85M
Protara Therapeutics, Inc.SH(TARA)1,900,0001,900,0000$3.95M$3.48M0.04%-$475.0K
Adagio Medical Holdings, Inc.SH(ADGM)01,333,926+1,333,926$0$3.44M0.04%+$3.44M
Surrozen, Inc.SH(SRZN)282,580282,5800$3.09M$3.39M0.04%+$291.1K
Metagenomi Therapeutics, Inc.SH(MGX)1,477,7491,305,239-172,510$6.03M$2.83M0.03%-$3.20M
Newamsterdam Pharma Co Nv-27SH
*W EXP 99/99/999
333,333333,3330$2.91M$2.33M0.03%-$573.3K
An2 Therapeutics IncSH5,551,2951,999,997-3,551,298$11.94M$2.14M0.02%-$9.80M
Regulus Therapeutics IncSH6,250,000766,834-5,483,166$11.16M$1.20M0.01%-$9.95M
Scilex Holding CompanySH(SCLX)261,179261,1790$504.1K$241.5K0.00%-$262.6K
Cybin D/B/A Helus PharmaSH(HELP)44,004,4640-44,004,464$11.93M$0—-$11.93M
Longboard Pharmaceuticals InSH3,289,1190-3,289,119$88.90M$0—-$88.90M
MacroGenics, Inc.SH(MGNX)2,082,0210-2,082,021$8.85M$0—-$8.85M
Unicycive Therapeutics IncSH2,632,2000-2,632,200$1.32M$0—-$1.32M
UroGen Pharma Ltd.SH(URGN)3,083,4300-3,083,430$51.74M$0—-$51.74M
Nurix Therapeutics, Inc.SH(NRIX)650,0000-650,000$13.57M$0—-$13.57M
Page 1 of 1
RA CAPITAL MANAGEMENT, L.P. — 13F Holdings — Q3 2024 | TickerTrail